Tobisawa Yuki

トビサワユウキ | Tobisawa Yuki

Affiliation and department：
Other affiliations (1)：

Institute for Advanced Study, Center for One Medicine Innovative Translational Research

Research field (4)： Immunology , Tumor biology , Urology , Cell biology

Research keywords (2)：ヒアルロン酸 , 糖鎖バイオマーカー

Research theme for competitive and other funds (10)：

2022 - 2024 多因子トランスオミックス解析で挑む口唇口蓋裂研究の新戦略
2021 - 2024 ヒアルロン酸分解酵素による前立腺癌の腫瘍免疫逃避機構の解明
2018 - 2021 Development of glycomolecule-based liquid biopsy marker for evaluation of prostate cancer malignancy
2018 - 2020 Development of novel cartilage regeneration therapy by glycotechnology
2017 - 2020 Tumor targeting using boron neutron capture therapy

Show all

Papers (151)：

Naotaka Kumada, Koji Iinuma, Yasuaki Kubota, Kimiaki Takagi, Masahiro Nakano, Takashi Ishida, Shigeaki Yokoi, Fumiya Sugino, Makoto Kawase, Shinichi Takeuchi, et al. Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study. Diseases (Basel, Switzerland). 2024. 12. 6
Masayuki Tomioka, Keita Nakane, Makoto Kawase, Koji Iinuma, Daiki Kato, Kota Kawase, Tomoki Taniguchi, Yuki Tobisawa, Fumiya Sugino, Tetsuro Kaga, et al. Discrepancy in the Location of Prostate Cancer Indicated on Biparametric Magnetic Resonance Imaging and Pathologically Diagnosed Using Surgical Specimens. Current oncology (Toronto, Ont.). 2024. 31. 5. 2846-2855
Hiroyuki Ito, Keita Nakane, Noriyasu Hagiwara, Makoto Kawase, Daiki Kato, Koji Iinuma, Kenichiro Ishida, Torai Enomoto, Minori Nezasa, Yuki Tobisawa, et al. Impact of Robotic-Assisted Partial Nephrectomy with Single Layer versus Double Layer Renorrhaphy on Postoperative Renal Function. Current oncology (Toronto, Ont.). 2024. 31. 5. 2758-2768
Fumiya Sugino, Keita Nakane, Makoto Kawase, Shota Ueda, Masayuki Tomioka, Yasumichi Takeuchi, Toyohiro Yamada, Sanae Namiki, Naotaka Kumada, Kota Kawase, et al. Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients. Journal of robotic surgery. 2023. 17. 5. 2441-2449
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Kazuyuki Mori, Teppei Okamoto, Hayato Yamamoto, et al. Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab. Scientific reports. 2023. 13. 1. 15098-15098

ｍore...

MISC (148)：

藤田尚紀, 米山徹, 飛澤悠葵, 百田匡毅, 大山力, 畠山真吾. 血清免疫グロブリンN-glycanの敗血症性血管内皮グリコカリックス傷害の保護効果. 泌尿器科分子・細胞研究会プログラム・抄録集. 2024. 33rd
大山力, 石川友一, 米山徹, 飛澤悠葵, 畠山真吾. Glycosylation of Prostate Specific Antigen (PSA) and its clinical implication. 日本糖質学会年会要旨集. 2022. 41st
濱谷智子, 畠山真吾, 米山徹, 飛澤悠葵, 小玉寛健, 藤田雄, 村上礼一, 岡本哲平, 山本勇人, 米山高弘, et al. 当科における腎移植レシピエントのmRNAコロナワクチン2回目接種後の抗体価. 日本泌尿器科学会東部総会プログラム・抄録集. 2022. 87th
阿南剛, 阿南剛, 米山徹, 野呂大輔, 飛澤悠葵, 畠山真吾, 米山美穂子, 山本勇人, 今井篤, 米山高弘, et al. 尿路結石形成に関与する糖鎖変異オステオポンチンの検索. 日本内分泌学会雑誌. 2021. 97. Suppl. Update (Web)
小玉寛健, 米山徹, 田中壽和, 野呂大輔, 須藤晋一郎, 飛澤悠葵, 山本勇人, 畠山真吾, 米山高弘, 橋本安弘, et al. 血清イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法. 日本癌治療学会学術集会(Web). 2021. 59th

ｍore...

Patents (10)：

ｍore...

Lectures and oral presentations (1)：

マウス個体レベルでのヒアルロン酸代謝機構におけるTMEM2の役割
(第32回プロテオグライカンフォーラム 2023)

Education (2)：

2005 - 2010 University of Shizuoka Graduate School of Pharmaceutical Sciences
2001 - 2005 University of Shizuoka School of Pharmaceutical Sciences

Professional career (1)：

Ph.D. (University of Shizuoka Graduate School of Pharmaceutical Sciences)

Work history (5)：

2023/04 - 現在 Gifu University University Hospital
2012/04 - 2023/03 Hirosaki University Graduate School of Medicine Assistant Professor
2016/04 - 2021/03 Sanford Burnham Prebys Medical Discovery Institute Researcher
2011/07 - 2012/03 Hirosaki University Graduate School of Medicine Researcher
2010/04 - 2011/06 Sanford Burnham Medical Research Institute Post Doc

Awards (3)：

2022 - 第6回箱守仙一郎賞奨励賞
2021 - 第4回櫻井記念医学研究賞特別賞
2015 - 第9回東北糖鎖研究会みちのく糖鎖ポスター賞

Association Membership(s) (2)：

日本糖質学会 , 生化学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page